share_log

中国再生医学因“10并1”基准进行股份合并而削减25.69亿股

China Regenerative Medicine cut 2,569 million shares due to share mergers on a “10 to 1” basis

新浪港股 ·  Sep 6, 2023 20:36

China Regenerative Medicine (08158) announced a reduction of 2.569 billion shares due to a share merger based on the "10 and 1" benchmark.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment